tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Kontafarma China Holdings to Review Interim Results and Dividend

Story Highlights
Kontafarma China Holdings to Review Interim Results and Dividend

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Kontafarma China Holdings Ltd ( (HK:1312) ) just unveiled an update.

Kontafarma China Holdings Limited has announced that its board of directors will meet on August 28, 2025, to consider and approve the interim results for the six months ended June 30, 2025, and discuss the potential payment of an interim dividend. This announcement may impact the company’s financial outlook and provide insights into its operational performance, potentially affecting stakeholders’ expectations.

More about Kontafarma China Holdings Ltd

Average Trading Volume: 1,049,094

Technical Sentiment Signal: Sell

Current Market Cap: HK$184.1M

Find detailed analytics on 1312 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1